Projects: Data Analysis - Baseline
Home arrow Projects: Data Analysis arrow Page 2 - Bayer: The Drug Development Clock is Ticking













Renew Your Subscription

Projects: Data Analysis



Bayer: The Drug Development Clock is Ticking



By Baselinemag

  Table of Contents:
  1. Bayer: The Drug Development Clock is Ticking
  2. ' Bayer AG Base Case '

For Bayer, computing technology could shave years off the time it takes to bring drugs to market. But what's the payoff for the drug industry?

Rate This Article:
Add This Article To:

Bayer: The Drug Development Clock is Ticking - ' Bayer AG Base Case '


( Page 2 of 2 )

Bayer AG Base Case

Headquarters: Leverkusen, Germany

Business: Bayer AG is one of the world's biggest pharmaceutical makers, best known for its eponymous aspirin, its Cipro antibiotic, Alka-Seltzer remedy and One-A-Day vitamins. Besides drugs, its operations include consumer-care products and chemicals.

Chief Technology Officer: Achim Noack

Drug sales in 2001: $4.2 billion

Challenge faced: Using information technology to increase the number of drug possibilities for Bayer

Baseline Goals:

  • Increase the percentage of drugs that make it out of clinical trials and get onto the market to 14% from 11% currently
  • Put at least two new drugs on the market annually
  • Bring 20 candidates to clinical trial in 2002



     
     
    >>> More Projects: Data Analysis Articles          >>> More By Baselinemag
     


  • Sponsored Links
  • Get up and running in as quickly as 30 days with BI. Learn how today.

  • FREE Securing Smartphones & Tablets for Dummies Book from Sophos
  • 5 New Technologies That Will Change Enterprise ITAdvertisement
  • Build an IT Infrastructure That Delivers the Future
     
  •  
    FEATURED SPONSORED ARTICLES

    FEATURED SPONSORED VIDEOS

     



    LATEST STORIES


     

     


    Advertisement
    rss graphic
           Baseline Newsletters